1-Ethyl-6-aminouracil

CAS No. 41862-09-3

1-Ethyl-6-aminouracil( 6-AMINO-1-ETHYL-1H-PYRIMIDINE-2,4-DIONE )

Catalog No. M22255 CAS No. 41862-09-3

1-Ethyl-6-aminouracil is an intermediate in the synthesis of a series of new substituted Xanthines which have high affinity and selectivity for the human adenosine A2B receptors.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 48 In Stock
5MG 68 In Stock
10MG 96 In Stock
25MG 174 In Stock
50MG 256 In Stock
100MG 384 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    1-Ethyl-6-aminouracil
  • Note
    Research use only, not for human use.
  • Brief Description
    1-Ethyl-6-aminouracil is an intermediate in the synthesis of a series of new substituted Xanthines which have high affinity and selectivity for the human adenosine A2B receptors.
  • Description
    1-Ethyl-6-aminouracil is an intermediate in the synthesis of a series of new substituted Xanthines which have high affinity and selectivity for the human adenosine A2B receptors.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    6-AMINO-1-ETHYL-1H-PYRIMIDINE-2,4-DIONE
  • Pathway
    Apoptosis
  • Target
    Adenosine Receptor
  • Recptor
    A2B?adenosine receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    41862-09-3
  • Formula Weight
    155.16
  • Molecular Formula
    C6H9N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCn1c(N)cc(=O)nc1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • A2A receptor antagon...

    A2A receptor antagonist 1 is an antagonist of both adenosine A2A receptor and A1 receptor with Kis of 4 and 264 nM, respectively.

  • CI-947

    An orally active adenosine receptor agonist that can induce acute cardiovascular toxicity and coronary vascular injury in vivo.

  • Rolofylline

    A potent, selective and orally active adenosine A1 receptor antagonist with Ki of 1.3 nM.